Janić M - Search Results

1

The Role of Lipid Metabolism in Dyslipidemias and Atherosclerosis.

Janić M, Yamashita S, Su TC, Rizzo M. Janić M, et al. Metabolites. 2024 Nov 6;14(11):596. doi: 10.3390/metabo14110596. Metabolites. 2024. PMID: 39590832 Free PMC article.

2

Treatment with low-dose atorvastatin, losartan, and their combination increases expression of vasoactive-related genes in rat aortas.

Lunder M, Drevenšek G, Černe D, Marc J, Janić M, Šabovič M. Lunder M, et al. Among authors: janic m. J Cardiovasc Pharmacol Ther. 2013 Mar;18(2):177-83. doi: 10.1177/1074248412463966. Epub 2012 Oct 22. J Cardiovasc Pharmacol Ther. 2013. PMID: 23091284

3

Low-dose atorvastatin, losartan, and particularly their combination, provide cardiovascular protection in isolated rat heart and aorta.

Lunder M, Ziberna L, Janić M, Jerin A, Skitek M, Sabovič M, Drevenšek G. Lunder M, et al. Among authors: janic m. Heart Vessels. 2013 Mar;28(2):246-54. doi: 10.1007/s00380-012-0259-0. Epub 2012 May 21. Heart Vessels. 2013. PMID: 22610592

4

The effects of low-dose fluvastatin and valsartan combination on arterial function: a randomized clinical trial.

Lunder M, Janić M, Jug B, Sabovič M. Lunder M, et al. Among authors: janic m. Eur J Intern Med. 2012 Apr;23(3):261-6. doi: 10.1016/j.ejim.2011.11.011. Epub 2011 Dec 12. Eur J Intern Med. 2012. PMID: 22385885 Clinical Trial.

5

Reduction of age-associated arterial wall changes by low-dose valsartan.

Lunder M, Janic M, Sabovic M. Lunder M, et al. Among authors: janic m. Eur J Prev Cardiol. 2012 Dec;19(6):1243-9. doi: 10.1177/1741826711423104. Epub 2011 Sep 20. Eur J Prev Cardiol. 2012. PMID: 21933833 Clinical Trial.

6

A combination of low-dose fluvastatin and valsartan decreases inflammation and oxidative stress in apparently healthy middle-aged males.

Janić M, Lunder M, Prezelj M, Šabovič M. Janić M, et al. J Cardiopulm Rehabil Prev. 2014 May-Jun;34(3):208-12. doi: 10.1097/HCR.0000000000000027. J Cardiopulm Rehabil Prev. 2014. PMID: 24263076

7

Associations among different functional and structural arterial wall properties and their relations to traditional cardiovascular risk factors in healthy subjects: a cross-sectional study.

Lunder M, Janic M, Kejzar N, Sabovic M. Lunder M, et al. Among authors: janic m. BMC Cardiovasc Disord. 2012 Apr 25;12:29. doi: 10.1186/1471-2261-12-29. BMC Cardiovasc Disord. 2012. PMID: 22533480 Free PMC article.

8

Effect of Oral Semaglutide on Cardiovascular Parameters and Their Mechanisms in Patients with Type 2 Diabetes: Rationale and Design of the Semaglutide Anti-Atherosclerotic Mechanisms of Action Study (SAMAS).

Janić M, Rizzo M, Cosentino F, Pantea Stoian A, Lunder M, Šabović M, Janež A. Janić M, et al. Diabetes Ther. 2022 Apr;13(4):795-810. doi: 10.1007/s13300-022-01226-y. Epub 2022 Mar 8. Diabetes Ther. 2022. PMID: 35258841 Free PMC article.

9

Glucometabolic Efficacy of the Empagliflozin/Metformin Combination in People with Type 1 Diabetes and Increased Cardiovascular Risk: A Sub-Analysis of a Pilot Randomized Controlled Trial.

Janić M, Janež A, Šabović M, El-Tanani M, Rangraze I, Rizzo M, Lunder M. Janić M, et al. J Clin Med. 2024 Nov 14;13(22):6860. doi: 10.3390/jcm13226860. J Clin Med. 2024. PMID: 39598003 Free PMC article.

10

Novel antidiabetic therapies in patients with peripheral artery disease: current perspective.

Janić M, Maggio V, Janež A, Rizzo M. Janić M, et al. Front Clin Diabetes Healthc. 2024 Nov 26;5:1517265. doi: 10.3389/fcdhc.2024.1517265. eCollection 2024. Front Clin Diabetes Healthc. 2024. PMID: 39659952 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters